Advertisement

Experientia

, Volume 36, Issue 4, pp 479–483 | Cite as

Scope and limitations of experimental chemotherapy

Article

Keywords

Meningitis Pyelonephritis Sande Antibiotic Concentration Discriminative Model 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    R.J. Arko, Science177, 1200 (1972).CrossRefPubMedGoogle Scholar
  2. 2.
    R.J. Arko, Lab. Anim. Sci.23, 105 (1973).PubMedGoogle Scholar
  3. 3.
    J.G. Bartlett, A.B. Onderdonk, T. Louie and S.L. Grobach, in: Chemotherapy, vol. 2, p. 249. Ed. J.D. Williams and A.M. Geddes. Plenum Press, New York and London 1976.Google Scholar
  4. 4.
    M. Barza, J. Brusch, M.G. Bergeron and L. Weinstein, J. infect. Dis.129, 73 (1974).CrossRefPubMedGoogle Scholar
  5. 5.
    M. Barza, Scand, J. infect. Dis. Suppl.14, 109 (1978).Google Scholar
  6. 6.
    M.G. Bergeron, Scand, J. infect. Dis., Suppl.14, 189 (1978).Google Scholar
  7. 7.
    S.E. Burrous and J.B. Cawein, Appl. Microbiol.18, 448 (1969).PubMedPubMedCentralGoogle Scholar
  8. 8.
    K.R. Comber, C.D. Osborne and R. Sutherland, in: Chemotherapy, vol. 2, p. 191. Ed. J.D. Williams and A.M. Geddes. Plenum Press, New York and London 1976.Google Scholar
  9. 9.
    K.R. Comber, C.D. Osborne and R. Sutherland, in: Chemotherapy, vol. 2, p. 259. Ed. J.D. Williams and A.M. Geddes. Plenum Press, New York and London 1976.Google Scholar
  10. 10.
    K.R. Comber, R.J. Boon and R. Sutherland, Antimicrob. Ag. Chemother.12, 736 (1977).CrossRefGoogle Scholar
  11. 11.
    R. Comichau, Thesis, Lübeck 1970.Google Scholar
  12. 12.
    G.K. Daikos and L. Weinstein, Klin. Wschr.38, 521 (1960).CrossRefPubMedGoogle Scholar
  13. 13.
    D.C. Dale, H.Y. Reynolds, J.E. Pennington, R.J. Elin and G.P. Herzig, Blood47, 869 (1976).PubMedGoogle Scholar
  14. 14.
    S.D. Davis and J.W. Chandler, Antimicrob. Ag. Chemother.8, 350 (1975).CrossRefGoogle Scholar
  15. 15.
    P. Ehrlich, Lancet2, 445 (1913).Google Scholar
  16. 16.
    U. Forsgren, B. Ekström, L.-P. Jalar and L. Magni, Scand. J. infect. Dis.14, 207 (1978).Google Scholar
  17. 17.
    L.R. Freedman and P.B. Beeson, Yale J. Biol. Med.30, 406 (1957).Google Scholar
  18. 18.
    L.R. Freedman and G. Demierre, in: Chemotherapy, vol. 2, p. 197. Ed. J.D. Williams and A.M. Geddes. Plenum Press, New York and London 1976.Google Scholar
  19. 19.
    P.K. Garrison and L.R. Freedman, Yale J. Biol. Med.42, 394 (1970).PubMedPubMedCentralGoogle Scholar
  20. 20.
    F.C. Goble and E.A. Konopka, Trans, N.Y. Acad. Sci. Series II,35, 325 (1973).CrossRefGoogle Scholar
  21. 21.
    K. Goitein, J. Michel and T. Sacks, Chemotherapy21, 181 (1975).CrossRefPubMedGoogle Scholar
  22. 22.
    J.W. Gowen, J. natl. Canc. Inst.15, 555 (1954).Google Scholar
  23. 23.
    R.H. Gorrill, in: Urinary tract infections, p. 24. Ed. F. O'Grady and W. Brumfit. London 1968.Google Scholar
  24. 24.
    D.H. Harter and R.G. Petersdorf, Yale J. Biol. Med.32, 280 (1960).PubMedPubMedCentralGoogle Scholar
  25. 25.
    R.H. Heptinstall, Br. J. exp. Path.45, 436 (1964).Google Scholar
  26. 26.
    E.W. Hook and M.A. Sande, Inf. Immun.10, 1433 (1974).Google Scholar
  27. 27.
    P.A. Hunter, G.N. Rolinson and D.A. Witting, Antimicrob. Ag. Chemother.4, 285 (1973).CrossRefGoogle Scholar
  28. 28.
    P.A. Hunter, G.N. Rolinson and D.A. Witting, in: Chemotherapy, vol. 2, p. 289. Ed. J.D. Williams and A.M. Geddes. Plenum Press, New York and London 1976.Google Scholar
  29. 29.
    G.G. Jackson, in: Progress in Pyelonephritis, p. 191. Ed. E.H. Kass. F.A. Davis Company, Philadelphia 1965.Google Scholar
  30. 30.
    S.K. Juhn, G.S. Giebink, D.G. Hanson and M.M. Paparella, Arch. Otorhinolaryngol.215, 95 (1977).CrossRefPubMedGoogle Scholar
  31. 31.
    E.A. Konopka, H.C. Zoganas, L. Lewis and J. Gelzer, Antimicrob. Ag. Chemother. 519 (1968).Google Scholar
  32. 32.
    E.A. Konopka, H.C. Zoganas, E.F. Kimble and H. Heymann, 16th Intersc. Conf. Antimicrob. Ag. Chemother., abstr. No. 345 (1976).Google Scholar
  33. 33.
    E.A. Konopka, H.C. Zoganas, E.R. Lasinski, E.F. Kimble and H. Heymann, in: Current Chemotherapy. vol. 2, p. 844. Ed. by. W. Siegenthaler and R. Lüthy. Am. Soc. Thicrobiol., Washington, D.C. 1978.Google Scholar
  34. 34.
    M.W. Kunst and H. Mattie, J. infect. Dis.137, 830 (1978).CrossRefPubMedGoogle Scholar
  35. 35.
    J.T. Litchfield and F. Wilcoxon, J. Pharmac. exp. Ther.96, 99 (1949).Google Scholar
  36. 36.
    V. Lorian, M. Koike, O. Zak, U. Zanon, L.D. Sabath, G.G. Grassi and W. Stille, in: Current Chemotherapy, vol. 1, p. 72. Ed. W. Siegenthaler and R. Lüthy. Am. Soc. Microbiol., Washington, D.C. 1978.Google Scholar
  37. 37.
    R.M. Lumich and C.W. Norden, J. infect. Dis.133, 538 (1976).CrossRefGoogle Scholar
  38. 38.
    A.K. Miller, Adv. appl. Microbiol.14, 151 (1971).CrossRefPubMedGoogle Scholar
  39. 39.
    K. Mohan, R.C. Gordon, T.C. Beaman, R.C. Belding, D. Luecke, C. Edmiston and P. Gerhardt, J. infect. Dis.135, 51 (1977).CrossRefPubMedGoogle Scholar
  40. 40.
    J. Morganroth and R. Levy, Klin, Wschr.48, 1979 (1911).Google Scholar
  41. 41.
    C.W. Norden, J. infect. Dis.122, 410 (1970).CrossRefPubMedGoogle Scholar
  42. 42.
    C.W. Norden, J. infect. Dis.132, 493 (1975).CrossRefPubMedGoogle Scholar
  43. 43.
    F. O'Grady, in: Chemotherapy, vol. 2, p. 177. Ed. J.D. Williams and A.M. Geddes. Plenum Press, New York and London 1976.Google Scholar
  44. 44.
    V. Prat, L. Konickova, W. Ritzerfeld and H. Losse, Z. Ges. exp. Med.146, 115 (1968).CrossRefGoogle Scholar
  45. 45.
    G.N. Rolinson, in: Chemotherapy, vol. 2, p. 183. Ed. J.D. Williams and A.M. Geddes. Plenum Press, New York and London 1976.Google Scholar
  46. 46.
    H. Rosin, in: Progress in Chemotherapy, vol. 1, p. 634. Ed. G.K. Daikos. Hellenic Soc. Chemother., 1973.Google Scholar
  47. 47.
    E. Rubinstein and M. Dan. Drugs exp. clin. Res.5, 281 (1979).Google Scholar
  48. 48.
    D.M. Ryan, Postgrad, Med. J., Suppl.46, 19 (1970).Google Scholar
  49. 49.
    D.M. Ryan, in: Chemotherapy, vol. 2, p. 205. Ed. J.D. Williams and A.M. Geddes. Plenum Press, New York and London 1976.Google Scholar
  50. 50.
    D.M. Ryan, Scand, J. infect. Dis., Suppl.13, 58 (1978).Google Scholar
  51. 51.
    W. Sackmann, Chemotherapy16, 196 (1971).CrossRefPubMedGoogle Scholar
  52. 52.
    W. Sackmann, Chemotherapy16, 203 (1971).CrossRefPubMedGoogle Scholar
  53. 53.
    M.A. Sande, C.R. Bowman and R.A. Calderone, Inf. Immun.17, 140 (1977).Google Scholar
  54. 54.
    M.A. Sande, R.J. Sherertz, O. Zak and L.J. Strausbaugh, J. Infect. Dis., Suppl.137, S161 (1978).CrossRefGoogle Scholar
  55. 55.
    H.J. Scholer, Path. Microbiol.23, 62 (1960).Google Scholar
  56. 56.
    F.R. Selbie and R.D. Simon, Br. J. exp. Path.33, 315 (1952).Google Scholar
  57. 57.
    L.J. Strausbaugh, C.D. Mandaleris and M.A. Sande, J. infect. Dis.135, 210 (1977).CrossRefPubMedGoogle Scholar
  58. 58.
    L.J. Strausbaugh and M.A. Sande, J. infect. Dis.137, 251 (1978).CrossRefPubMedGoogle Scholar
  59. 59.
    W. Tosch, O. Zak, P. Schneider and E. Batt, in: Proc. 11th Int. Congr. Chemother. 1980, accepted for publication.Google Scholar
  60. 60.
    Y.H. Tsai, E.B. Williams, R.S. Hirth and K.E. Price, Chemotherapy21, 342 (1975).CrossRefPubMedGoogle Scholar
  61. 61.
    K. Tsuchiya, M. Kondo and H. Nagatomo, Antimicrob. Ag. Chemother.13, 137 (1978).CrossRefGoogle Scholar
  62. 62.
    W.A. Vischer, Chemotherapy17, 293 (1972).CrossRefPubMedGoogle Scholar
  63. 63.
    E. Vivaldi, R. Cotran, D.P. Zangwill and E.H. Kass, Proc. Soc. exp. Biol. Med.102, 242 (1959).CrossRefGoogle Scholar
  64. 64.
    W.M. Weinstein, A.B. Onderdonk, J.G. Bartlett, T.J. Louie and S.L. Gorbach, J. infect. Dis.132, 282 (1975).CrossRefPubMedGoogle Scholar
  65. 65.
    W.E. Wick, F. Streightoff and D.H. Holmes, J. Bact.81, 233 (1961).PubMedPubMedCentralGoogle Scholar
  66. 66.
    U.-W. Wiegand, H. Weder and R. Haller, Arzneimittel-Forsch.25, 839 (1975).Google Scholar
  67. 67.
    F. Zak, O. Zak, N. Zakova and J. Vaxelaire, in: 6th Congr. Eur. Soc. Path., 1977. abstr. No. B139.Google Scholar
  68. 68.
    O. Zak and F. Kradolfer, in: 11th I.C.A.A.C. 1971, abstr. No. 168.Google Scholar
  69. 69.
    O. Zak, W. Tosch, W.A. Vischer and F. Kradolfer, Drugs exp. clin. Res.3, 11 (1977).Google Scholar
  70. 70.
    O. Zak and F. Kradolfer, in: 17th I.C.A.A.C. 1977, abstr. Nr.418.Google Scholar
  71. 71.
    O. Zak, in: Infections of the Urinary Tract, p.224. Ed. E.H. Kass and W. Brumfitt, Univ. of Chicago Press, 1978.Google Scholar
  72. 72.
    O. Zak, E.A. Konopka, W. Tosch, T. Ahrens, W. Zimmermann and F. Kradolfer, Drugs exp. clin Res.5, 45 (1979).Google Scholar
  73. 73.
    O. Zak and F. Kradolfer, Rev. inf. Dis.1, 862 (1979).CrossRefGoogle Scholar
  74. 74.
    O. Zak, E.A. Konopka, W. Tosch, W. Zimmermann, S. Kunz, H. Fehlmann and F. Kradolfer, in: Proc. 11th Int. Congr. Chemother, in press (1980).Google Scholar
  75. 75.
    O. Zak, S. Kunz, L. Richard, B. Hengstler and J. Vaxelaire, in preparation.Google Scholar

Copyright information

© Birkhäuser Verlag 1980

Authors and Affiliations

  • O. Zak
    • 1
  1. 1.Research Department, Pharmaceuticals DivisionCiba-Geigy LtdBaselSwitzerland

Personalised recommendations